Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

• Jiefei Han,
• Yiting Dong,
• Xiuli Zhu,
• Alexandre Reuben,
• Jianjun Zhang,
• Jiachen Xu,
• Hua Bai,
• Jianchun Duan,
• Rui Wan,
• Jie Zhao,
• Jing Bai,
• Xuefeng Xia,
• Xin Yi,
• Chao Cheng,
• Jie Wang,
• Zhijie Wang

Affiliations

Jiefei Han

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Yiting Dong

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Xiuli Zhu

Geneplus-Beijing Institute

Alexandre Reuben

Department of Thoracic/ Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center

Jianjun Zhang

Department of Thoracic/ Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center

Jiachen Xu

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Hua Bai

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Jianchun Duan

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Rui Wan

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Jie Zhao

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Jing Bai

Geneplus-Beijing Institute

Xuefeng Xia

Geneplus-Beijing Institute

Xin Yi

Geneplus-Beijing Institute

Chao Cheng

Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Institute for Clinical and Translational Research, Baylor College of Medicine

Jie Wang

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Zhijie Wang

State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College